Etilefrine (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C01CA01
CAS registry number (Chemical Abstracts Service)
0000709-55-7
Chemical Formula
C10-H15-N-O2
Molecular Weight
181
Therapeutic Categories
Sympathomimetic agent
Antihypotensive agent
Chemical Name
Benzenemetanol, α-[(etylamino)metyl]-3-hydroxy-
Foreign Names
- Etilefrinum (Latin)
- Etilefrin (German)
- Étiléfrine (French)
- Etilefrina (Spanish)
Generic Names
- Etilefrina (OS: DCIT)
- Etilefrine (OS: BAN)
- Étiléfrine (OS: DCF)
- Aethyladrianol (IS)
- Etilefrine Hydrochloride (OS: BANM, JAN)
- Etiléfrine (chlorhydrae d') (PH: Ph. Eur. 9)
- Etilefrine Hydrochloride (PH: BP 2018, JP XVII)
- Etilefrine hydrochloride (PH: Ph. Eur. 9)
- Etilefrinhydrochlorid (PH: Ph. Eur. 9)
- Etilefrini hydrochloridum (PH: Ph. Eur. 9)
Brand Names
- Balkis [+ Chlorphenamine]
Eipico, Egypt - Effortil
Boehringer, Peru; Boehringer Ingelheim, Egypt; Boehringer Ingelheim, Tunisia; Sanolabor, Slovenia - Etilefrina Larjan
Veinfar, Paraguay - Etrifin
AC Farma, Peru - Hyposia
Asian Pharm, Thailand - Menegradil
Fada, Uruguay - Tonnary
Maver, Mexico - Vascon
hi pharm, Egypt - Vasopress
Ceci Farma, Peru - Bioflutin
Südmedica, Germany - Buracard
Burapha, Thailand - Cinbinin
Swiss Pharm, Taiwan - Effontil
Boehringer Ingelheim, Venezuela - Effortil
Boehringer Ing., Paraguay; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Costa Rica; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Dominican Republic; Boehringer Ingelheim, France; Boehringer Ingelheim, Guatemala; Boehringer Ingelheim, Honduras; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Luxembourg; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Nicaragua; Boehringer Ingelheim, Panama; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, El Salvador; Boehringer Ingelheim, Uruguay; Boehringer Ingelheim, South Africa; IFET, Greece; Sanofi, Japan; Sanofi Oy, Finland; Sanofi-Aventis, Austria; Unilfarma, Portugal - Effortil 7,5 mg/ml
Sanofi-Aventis, Austria - Effortil 7.5mg/g
Sanofi-Aventis, Switzerland - Efortil
Boehringer Ingelheim España, Spain - Etilefril
União Química, Brazil - Etilefrina Clorhidrato Lasca
Lasca, Paraguay - Etilefrina Larjan
Larjan, Uruguay - Étiléfrine Serb
SERB Laboratoires, France - Fortinil
Novophar, Paraguay - Fortinil Retard
Novophar, Paraguay
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.